Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps

Case study: A Combination of Mepolizumab and Omaluzimab injections for severe asthma

(2018) Rejmon Dedaj et al.   JOURNAL OF ASTHMA

Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review

(2018) N. Tsetsos et al.   RHINOLOGY

Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response

(2017) Jose Gurrola et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

(2017) Claus Bachert et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment

(2016) A. Magnan et al.   ALLERGY

Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis

(2016) Claus Bachert et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

015 Anti-IgE monoclonal antibody (omalizumab) in refractory and relapsing eosinophilic granulomatosis with polyangiitis: data from 17 patients

(2016) M. Jachiet et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Is there a future for biologics in the management of chronic rhinosinusitis?

(2016) Kent Lam et al.   International Forum of Allergy & Rhinology

Omalizumab therapy for refractory allergic fungal rhinosinusitis patients with moderate or severe asthma

(2015) Eng Cern Gan et al.   AMERICAN JOURNAL OF OTOLARYNGOLOGY

Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis

(2015) Claus Bachert et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme

(2015) Norbert Krug et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Association of serum periostin with aspirin-exacerbated respiratory disease

(2014) Mi-Ae Kim et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis

(2014) S. Baba et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab

(2014) Aidan Long et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease

(2012) K. Aksu et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma

(2012) Bradley E. Chipps et al.   ALLERGY AND ASTHMA PROCEEDINGS

Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

(2012) Philippe Gevaert et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma

(2011) Aasia Ghazi et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

(2011) Philippe Gevaert et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy of Targeted Medical Therapy in Chronic Rhinosinusitis, and Predictors of Failure

(2010) Devyani Lal et al.   American Journal of Rhinology & Allergy

Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese

(2009) Ping-Ping Cao et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Montelukast as an Adjunct to Oral and Inhaled Steroid Therapy in Chronic Nasal Polyposis

(2008) Rosemary A. Stewart et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY